The PE Ratio as of December 2025 (TTM) for Ascelia Pharma AB (publ) (ACE.ST) is -4.08

According to Ascelia Pharma AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -4.08. This represents a change of -5.91% compared to the average of -4.34 of the last 4 quarters.

Ascelia Pharma AB (publ) (ACE.ST) Historical PE Ratio (quarterly & annually)

How has ACE.ST PE Ratio performed in the past?

The mean historical PE Ratio of Ascelia Pharma AB (publ) over the last ten years is -8.30. The current -4.08 PE Ratio has changed 4.81% with respect to the historical average. Over the past ten years (40 quarters), ACE.ST's PE Ratio was at its highest in in the September 2024 quarter at -1.31. The PE Ratio was at its lowest in in the March 2018 quarter at -31.87.

Ascelia Pharma AB (publ) (ACE.ST) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Ascelia Pharma AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ascelia Pharma AB (publ) (ACE.ST) Average PE Ratio

How has ACE.ST PE Ratio performed in the past?

The current PE Ratio of Ascelia Pharma AB (publ) (ACE.ST) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Ascelia Pharma AB (publ) (ACE.ST) PE Ratio vs. Peers

How is ACE.ST’s PE Ratio compared to its peers?

Ascelia Pharma AB (publ)’s PE Ratio is less than Mendus AB (publ) (-2.43), greater than Intervacc AB (publ) (-4.83), greater than Magle Chemoswed Holding AB (publ) (-12.81), greater than Xintela AB (publ) (-4.20), less than Moberg Pharma AB (publ) (-1.64), less than Karolinska Development AB (publ) (-0.75), greater than Elicera Therapeutics AB (publ) (-21.88), less than Isofol Medical AB (publ) (-3.43), less than Lipum AB (publ) (-4.04), less than IRLAB Therapeutics AB (publ) (-1.79),

Build a custom stock screener for Ascelia Pharma AB (publ) (ACE.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ascelia Pharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ascelia Pharma AB (publ) (ACE.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ascelia Pharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.